Loading vulnerability…
CVE-2024-38194 is a critical elevation of privilege vulnerability in Azure Web Apps. The issue is described as an improper authorization flaw, with some reporting also characterizing it as improper input validation. A remote authenticated attacker could exploit the vulnerability over the network to obtain privileges beyond those intended within the Azure Web Apps environment. Specific vulnerable functions or code paths are not publicly detailed in the available information.
Mallory correlates every CVE against your assets, your vendors, and active adversary campaigns. Know which vulnerabilities matter for you, not just which ones are loud.
What it means. What to do now. Patch path, mitigations, and the assume-compromise checklist.
What an attacker gets, and what they’ve been doing with it.
If you can’t patch tonight, do this now.
Patch, then assume compromise.
No public exploits tracked yet. Mallory keeps watching.
No public exploit code observed for this vulnerability.
Products and vendors Mallory has correlated with this vulnerability. Open in Mallory to drill down to specific CPE configurations and version ranges.
Vendor-confirmed product mapping. Mallory continuously reconciles this list against your asset inventory.
4 sources tracked across advisories, community write-ups, and news. New activity surfaces here as Mallory finds it.
Privilege escalation vulnerability in Azure Web Apps due to improper input validation; Microsoft has already remediated it server-side.
Azure Stack Hub elevation-of-privilege vulnerability (critical).
An elevation of privilege vulnerability in Azure Web Apps.
Query your assets running an affected version, and investigate the blast radius.
Every observed campaign linking this CVE to a named adversary.
Malware families riding this exploit, with evidence and IOCs.
YARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Cross-references every affected SKU, including bundled OEM variants.
Community discussion across Reddit, Mastodon, and other social sources.